Constitutive Expression of AID Leads to Tumorigenesis

Genome stability is regulated by the balance between efficiencies of the repair machinery and genetic alterations such as mutations and chromosomal rearrangements. It has been postulated that deregulation of class switch recombination (CSR) and somatic hypermutation (SHM), which modify the immunoglobulin (Ig) genes in activated B cells, may be responsible for aberrant chromosomal translocations and mutations of non-Ig genes that lead to lymphocyte malignancy. However, the molecular basis for these genetic instabilities is not clearly understood. Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce both CSR and SHM in artificial substrates in fibroblasts as well as B cells. Here we show that constitutive and ubiquitous expression of AID in transgenic mice caused both T cell lymphomas and dysgenetic lesions of epithelium of respiratory bronchioles (micro-adenomas) in all individual mice. Point mutations, but not translocations, were massively introduced in expressed T cell receptor (TCR) and c-myc genes in T lymphoma cells. The results indicate that AID can mutate non-Ig genes including oncogenes, implying that aberrant AID expression could be a cause of human malignancy.

[1]  J. Weitzman,et al.  Somatic hypermutation , 2020, Genome Biology.

[2]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[3]  M. Neuberger,et al.  Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase , 2002, Nature.

[4]  Alberto Martin,et al.  Somatic hypermutation of the AID transgene in B and non-B cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Neuberger,et al.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.

[6]  T. Honjo,et al.  AID Enzyme-Induced Hypermutation in an Actively Transcribed Gene in Fibroblasts , 2002, Science.

[7]  T. Honjo,et al.  The AID enzyme induces class switch recombination in fibroblasts , 2002, Nature.

[8]  Alberto Martin,et al.  Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas , 2002, Nature.

[9]  T. Honjo,et al.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation. , 2002, Annual review of immunology.

[10]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[11]  T. Honjo,et al.  Quantitative Regulation of Class Switch Recombination by Switch Region Transcription , 2001, The Journal of experimental medicine.

[12]  Gouri Nanjangud,et al.  Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas , 2001, Nature.

[13]  T. Ludwig,et al.  Tumorigenesis in mice carrying a truncating Brca1 mutation. , 2001, Genes & development.

[14]  A. Fischer,et al.  Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.

[15]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[16]  T. Honjo,et al.  Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.

[17]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[18]  J. Hackett,et al.  Cis‐acting sequences that affect somatic hypermutation of Ig genes , 1998, Immunological reviews.

[19]  A. Ashworth,et al.  Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation , 1997, Nature Genetics.

[20]  T. Innerarity,et al.  A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. , 1997, Genes & development.

[21]  Thomas Ried,et al.  Multicolour spectral karyotyping of mouse chromosomes , 1996, Nature Genetics.

[22]  Francis Collins,et al.  Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia , 1996, Cell.

[23]  H. Griesser,et al.  MSH2 deficient mice are viable and susceptible to lymphoid tumours , 1995, Nature Genetics.

[24]  J. Taylor,et al.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Radman,et al.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer , 1995, Cell.

[26]  M. Raffeld,et al.  Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences. , 1995, Current topics in microbiology and immunology.

[27]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[28]  C. Burant,et al.  Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.

[29]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[30]  M. Groudine,et al.  Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. , 1987, Science.

[31]  T. Honjo,et al.  Expression and rearrangement of the alpha, beta, and gamma chain genes of the T cell receptor in cloned murine large granular lymphocyte lines. No correlation with the cytotoxic spectrum , 1986, The Journal of experimental medicine.

[32]  T. Rabbitts,et al.  Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma , 1983, Nature.